ICA Group Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$58.6K Sell
1,410
-2,555
-64% -$114K 0.04% 227
2024
Q1
$215K Buy
3,965
+255
+7% +$13K 0.04% 266
2023
Q4
$190K Hold
3,710
0.04% 263
2023
Q3
$215K Hold
3,710
0.06% 212
2023
Q2
$237K Sell
3,710
-2,017
-35% -$135K 0.06% 204
2023
Q1
$397K Buy
5,727
+82
+1% +$5.78K 0.09% 173
2022
Q4
$406K Sell
5,645
-2,258
-29% -$170K 0.1% 176
2022
Q3
$562K Buy
7,903
+67
+0.9% +$4.86K 0.12% 172
2022
Q2
$590K Sell
7,836
-241
-3% -$18.4K 0.11% 174
2022
Q1
$608K Buy
+8,077
New +$542K 0.12% 173

Other funds holding BMY

ICA Group Wealth Management's BMY Position: Q2 2024 in Review

ICA Group Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 64% in Q2 2024, selling an estimated $114K and leaving 1,410 shares worth $58.6K. The position accounts for 0.04% of the portfolio, ranked #227.

ICA Group Wealth Management first reported a position in BMY in Q1 2022 and has held it in 10 quarters since. The position peaked at $608K in Q1 2022. 2,147 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

  • ICA Group Wealth Management held 1,410 shares of Bristol-Myers Squibb worth $58.6K as of Q2 2024.
  • ICA Group Wealth Management sold 2,555 Bristol-Myers Squibb shares in Q2 2024, an estimated $114K.
  • Bristol-Myers Squibb made up 0.04% of ICA Group Wealth Management's portfolio in Q2 2024, its #227 holding.
  • ICA Group Wealth Management first reported a position in Bristol-Myers Squibb in Q1 2022 and has held it in 10 quarters since.
  • ICA Group Wealth Management's Bristol-Myers Squibb position peaked at $608K in Q1 2022.
  • 2,147 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.